Asian Spectator

MediConCen Secures Series A Funding to Drive Global Expansion

  • Written by MediConCen
HONG KONG SAR - Media OutReach Newswire[1] - 7 February 2024 - MediConCen Limited, an Insurtech company that automates insurance claims using AI and blockchain, announced that it has raised USD 6.85 million in its latest Series A round. The new funding is led by HSBC Asset Management and has also received support from existing investors including G&M Capital, ParticleX, and new investor Wings Capital Ventures. To date, MediConCen received USD 12.7 million, and this new investment will accelerate its growth in the international market, including the Middle East and Southeast Asia.

(From left to right) Mr. Kelvin Yeung, Co-Founder & COO of MediConCen; Mr. William Yeung, Co-Founder & CEO of MediConCen and Ms. Jenny Lau, Co-Founder & CMO of MediConCen

"Insurance does good for the society but often it is not felt by the customers. There is much frustration dealing with the medical claim process for both customers and insurers alike. We always aim to create a 10x better customer experience, and we believe that insurance claims are the most pressing area to address. MediConCen's capability to deliver extraordinary solutions lies in our profound understanding of insurance and state-of-the-art technology. We are changing the paper-based and human-based claim process to digital- and AI-assisted journey, utilising the latest AI and blockchain technology. We are glad to have the Venture Capital team at HSBC Asset Management join us as an investor supporting our mission to revolutionise the insurance claim experience" said William Yeung, CEO and co-founder of MediConCen.

"Given our operational background in financial products and services, we are true believers in the transformational effect of digitization. Insurance's true value is realised the moment policyholders experience an insured event. We are supportive of MediConCen's aim to improve this experience by simplifying and speeding up the claims journey, including ensuring that the claim amount is fair, with a technology backbone that supports the scaling up of these benefits." Said Kara Byun, Head of Fintech, Venture & Growth Investments, HSBC Asset Management.

MediConCen is a Cyberport community start-up that had joined the Cyberport Incubation Programme in 2018 and benefited from the financial support and access to partners and networks. With the support of the Cyberport Macro Fund, an investment fund which provides seed to Series A stage and beyond funding to Cyberport digital entrepreneurs, MediConCen has successfully secured extra co-investments to facilitate its growth in 2020.

[2][3][4][5]

Hashtag: #MediConCen #HSBC #Insurtech #newfunding #seriesA #Insurance #claim #AI #blockchain

The issuer is solely responsible for the content of this announcement.

References

  1. ^ Media OutReach Newswire (www.media-outreach.com)
  2. ^ (mediconcen.com)
  3. ^ (hk.linkedin.com)
  4. ^ (www.facebook.com)
  5. ^ (www.instagram.com)

Authors: MediConCen

Read more https://www.media-outreach.com/news/hong-kong-sar/2024/02/07/277377/

Magazine

Di bawah standar WHO: 3 alasan anggaran kesehatan harus ditingkatkan di era Prabowo

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi telah mulai bekerja sejak 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #...

Teknologi baru sel surya tandem pecahkan rekor dunia dalam efisiensi energi

Thanun Vongsuravanich / ShutterstockPanel surya yang dipasang di atap rumah dan lahan pembangkit energi skala besar telah menjadi pemandangan biasa di berbagai belahan dunia. Tenaga surya kini menjadi...

Seperti ‘trick or treat’, film horor adalah ciri khas Halloween−tapi mengapa harus berdarah-darah?

Banyak sekali film horor di tahun 2024, dan banyak di antaranya yang mempertontonkan adegan berdarah secara terang-terangan. Tahun ini, sejumlah film ‘berdarah’ memasuki pasaran, seperti I...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion